Beginning in 2017, all dermatologists providing Medicare Part B services were required to participate in the Merit-Based Incentive Payment System (MIPS) or the Advanced Alternative Payment Model (AAPM).1 In MIPS, reporting of performance metrics determines a score that is used to determine a future fee adjustment. Although the Centers for Medicare & Medicaid Services (CMS) allowed physicians to avoid a negative adjustment in 2017 by submitting a single measure, future fee adjustments will be increasing and based on a score threshold. Amid the shift toward value-based care, it is important to understand MIPS participation and performance by dermatologists, including those who would benefit from resources to enhance engagement and performance.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Gronbeck C, Feng PW, Feng H. Participation and Performance of Dermatologists in the 2017 Merit-Based Incentive Payment System. JAMA Dermatol. Published online February 19, 2020. doi:10.1001/jamadermatol.2019.4860
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: